Alice Goodman | Authors


Prognostic Information in AML Gleaned From Timing of Genetic Mutations

September 02, 2015

A new study suggests that the presence of persistent genetic mutations, 30 days after induction chemotherapy, predicted relapse and survival in patients with acute myeloid leukemia (AML), as well as intermediate-risk patients.

Fewer Moles May Be Related to Aggressive Melanoma

August 21, 2015

It is well known that having multiple moles (ie, >50) is a risk factor for developing melanoma. A new study shows, however, that melanoma can also develop in people with fewer than 50 moles, and when it does, it typically has a more aggressive course.

Robot-Assisted Surgery Shows Good Survival and Less Blood Loss in Bladder Cancer

July 30, 2015

Patients with bladder cancer who undergo robot-assisted radical cystectomy (RARC) appear to have acceptable 5-year survival, according to the largest multi-institutional series to date to collect data on RARC outcomes in this population.